Mubadala’s KELIX bio acquires four GlobalOne Healthcare Holding pharma assets

Following the closing of the acquisition of KELIX bio, Mubadala Investment Company PJSC has empowered its new specialty More…

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2025 brokersgcc.com | All Rights Reserved
Disclaimer: brokersgcc.com provides reviews, insights, and analysis on financial markets and investment opportunities. We do not offer brokerage services or guarantee specific financial results. All investments carry risk, including the potential loss of capital. The information provided on this website is for informational purposes only and should not be considered as financial advice. Results may vary, and you should consult a professional financial advisor before making any investment decisions.

Risk Disclosure
Trading financial instruments, including currencies, involves significant risk and may result in the loss of your investment. Prices can fluctuate due to factors such as market conditions, regulatory changes, and geopolitical events. Past performance is not indicative of future results.

Usage Restrictions
No part of this website or its content may be reproduced, distributed, or transmitted in any form without prior written permission from brokersgcc.com.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Privacy Policy | Terms of Service | Refund Policy

Unit 1603, 16th Floor, The L. Plaza, 367-375 Queen’s Road Central, Sheung Wan, Hong Kong | Rmedia Limited